ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

In Brief: Cancer Control Month: Reagan Advises Americans To Stop Tobacco Use; Eat More Fiber, Less Fat

April 18, 1986

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005

Latest State Cancer Statistics Released.

January 14, 2005